The future of inflammatory bowel disease care. [electronic resource]
- Reviews in gastroenterological disorders 2009
- E69-77 p. digital
Publication Type: Journal Article; Review
1949-4386
Adalimumab Adrenal Cortex Hormones--therapeutic use Anti-Inflammatory Agents, Non-Steroidal--therapeutic use Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Azathioprine--therapeutic use Certolizumab Pegol Clinical Trials as Topic Gastrointestinal Agents--therapeutic use Humans Immunoglobulin Fab Fragments--therapeutic use Immunosuppressive Agents--therapeutic use Inflammatory Bowel Diseases--drug therapy Infliximab Mercaptopurine--therapeutic use Mesalamine--therapeutic use Natalizumab Polyethylene Glycols--therapeutic use Tumor Necrosis Factor-alpha--antagonists & inhibitors